Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Melanie I, Then"'
Autor:
Laura Weisbach, Anna K. Schuster, Michael Hartmann, Pauline Dürr, Melanie I. Then, Wahram Andrikyan, Martin F. Fromm, Renke Maas, Katrin Farker
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc67986c0ef3fc9e5fd67fb1ae0a20b
https://doi.org/10.1111/bcp.15730
https://doi.org/10.1111/bcp.15730
Autor:
Melanie I. Then, Thomas Tümena, Anna Sledziewska, Karl‐Günter Gaßmann, Renke Maas, Martin F. Fromm
Regulatory authorities put major emphasis on QT (interval)–prolonging properties of new molecular entities. Product information/Summaries of Product Characteristics (SmPCs) of multiple drugs contain warnings or contraindications regarding QT prolon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9b8b29b88f3e1363d110bd2bdfc660
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22692
https://opus4.kobv.de/opus4-fau/frontdoor/index/index/docId/22692
Publikováno v:
British Journal of Clinical Pharmacology. 88:226-236
Aims A substantial number of Summaries of Product Characteristics (SmPCs)/Prescribing Information (PI) have warnings or contraindications on QT interval prolongation. The goal of this work was to quantify usage of QT interval prolonging drugs accordi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::565ad42671fb2881d8db350e82ce2484
https://doi.org/10.1111/bcp.14951
https://doi.org/10.1111/bcp.14951
Autor:
Wahram Andrikyan, Melanie I. Then, Karl‐Günter Gaßmann, Thomas Tümena, Pauline Dürr, Martin F. Fromm, Renke Maas
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(12)
Aims Automated checks for medication‐related problems have become a cornerstone of medication safety. In many clinical settings medication checks remain confined to drug–drug interactions because only medication data are available in an adequatel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7433be72fc8f72d7a2243b5f82b9863d
https://pubmed.ncbi.nlm.nih.gov/35877931
https://pubmed.ncbi.nlm.nih.gov/35877931
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(1)
A substantial number of Summaries of Product Characteristics (SmPCs)/Prescribing Information (PI) have warnings or contraindications on QT interval prolongation. The goal of this work was to quantify usage of QT interval prolonging drugs according to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e3d0ad6a070b0cd6c08770cd03919141
https://pubmed.ncbi.nlm.nih.gov/34156728
https://pubmed.ncbi.nlm.nih.gov/34156728